--- title: "Beta-carotene: Dosing & Vendor Prices — BodyHackGuide" description: "Beta-carotene: dosing protocols, mechanism & side effects. Compare verified vendor prices." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Compounds", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "Beta-carotene" } ] }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "Beta-carotene", "description": "Beta-carotene is the most prominent provitamin A carotenoid and one of the most-studied dietary pigments in human nutrition. Chemically it is (all-E)-beta,beta-carotene — two symmetric beta-ionone rings connected by a central 18-carbon polyene chain with 11 conjugated double bonds. This symmetric bicyclic structure, with identical beta-ionone rings at both ends, distinguishes beta-carotene from its close dietary relatives: alpha-carotene has one beta-ring and one epsilon-ring; gamma-carotene has one beta-ring and an open-chain end; lycopene is fully acyclic with both ends as open isoprenoid chains; lutein and zeaxanthin are the hydroxylated xanthophyll counterparts. Only provitamin A carotenoids with at least one unsubstituted beta-ionone ring can be enzymatically cleaved to retinal (vitamin A) by the human enzyme beta-carotene 15,15'-oxygenase 1 (BCO1); beta-carotene has two such rings and is the most efficient dietary source of vitamin A among carotenoids. The dual role as an antioxidant and as a vitamin A precursor makes beta-carotene distinct from other dietary carotenoids. Unlike lycopene (no vitamin A activity), lutein and zeaxanthin (no vitamin A activity, eye-specific concentration), and astaxanthin (no vitamin A activity, systemic xanthophyll), beta-carotene contributes to vitamin A status in populations where preformed vitamin A intake is low. This is the primary nutritional rationale for beta-carotene fortification of food and for its use in vitamin A deficiency prevention programs in developing countries, particularly through Golden Rice and food fortification in sub-Saharan Africa and South Asia. Historical vitamin A intake, assessed in retinol activity equivalents (RAE), treats beta-carotene as contributing 1 RAE per 12 mcg of dietary beta-carotene (or 1 RAE per 24 mcg of other provitamin A carotenoids). This conversion reflects typical BCO1 cleavage efficiency in mixed dietary matrix and is substantially less efficient than preformed vitamin A from animal sources. The evidence landscape for beta-carotene supplementation underwent a major rethink following two landmark trials published in 1996. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC Study Group 1994, 1996) in 29,133 Finnish male smokers found that beta-carotene 20 mg daily increased lung cancer incidence by 18% and total mortality by 8%. The Beta-Carotene and Retinol Efficacy Trial (CARET, Omenn 1996 NEJM PMID 8602180) in 18,314 heavy smokers and asbestos-exposed workers found that beta-carotene 30 mg plus retinol 25,000 IU daily increased lung cancer incidence by 28% and total mortality by 17%, leading to early termination of the trial. The Physicians' Health Study (Hennekens 1996 NEJM PMID 8602179) in 22,071 predominantly non-smoking male physicians found that beta-carotene 50 mg every other day for 12 years had no effect on cancer or cardiovascular disease, providing reassurance that the smoker-specific signal did not extend to non-smokers. These trials transformed beta-carotene from a promising chemopreventive agent into a supplement with specific contraindication in smokers and former smokers. The AREDS2 trial (Chew 2013 JAMA PMID 23644932) replaced beta-carotene with lutein plus zeaxanthin in the second-generation AREDS formulation specifically because of the smoker safety concern. Current expert recommendations universally discourage isolated high-dose beta-carotene supplementation in current or former smokers, while dietary beta-carotene through food (carrots, sweet potatoes, pumpkin, leafy greens) is considered safe and beneficial in all populations. For non-smoking adults, beta-carotene remains a valid supplementation option within a multi-carotenoid stack, particularly for vitamin A status support in populations with low preformed vitamin A intake, for skin photoprotection, and for general antioxidant coverage. Dietary sources of beta-carotene are abundant: carrots contain 8-12 mg per 100 g, sweet potatoes 6-12 mg, kale 9 mg, spinach 5-6 mg, pumpkin 3-5 mg, apricots and mangoes 1-2 mg, cantaloupe 2-3 mg. A typical Western diet provides 2-5 mg of beta-carotene daily from these sources. Supplemental doses range from 3 mg (typical multivitamin) to 25 mg (standalone beta-carotene or mixed carotenoid formulations). Commercial beta-carotene for supplementation is produced by three routes: extraction from the microalga Dunaliella salina (natural 9-cis and all-trans isomer mixture, richest in 9-cis-beta-carotene which is not present in synthetic preparations), extraction from Blakeslea trispora fungal fermentation, and chemical synthesis (all-trans isomer only, historically used in CARET and ATBC). The Dunaliella-derived natural beta-carotene (BetaTene, Lyc-O-Beta natural, BASF natural beta-carotene) is often preferred because natural isomer mixtures have different bioavailability and tissue distribution compared to purely synthetic all-trans material, and because the natural preparation includes accompanying carotenoids (alpha-carotene, zeaxanthin traces) and tocopherols that may modulate the oxidative chemistry in more physiologic ways. Notably, the ATBC and CARET trials used synthetic all-trans-beta-carotene, and whether natural Dunaliella-derived beta-carotene would have produced the same smoker signal has been debated without definitive resolution; conservative practice treats natural and synthetic equivalently for the smoker contraindication. For bodyhackguide.co users, beta-carotene occupies a specific place in the nutritional landscape: vitamin A status support in vegetarian/vegan populations with limited preformed vitamin A intake, skin photoprotection when combined with other carotenoids, and general antioxidant stacking for non-smokers. It pairs with lutein and zeaxanthin (eye-specific xanthophylls without vitamin A activity), lycopene (prostate/cardiovascular acyclic carotenoid), astaxanthin (systemic xanthophyll), vitamin-e (membrane antioxidant synergism), and preformed vitamin-a (retinyl palmitate for populations needing guaranteed vitamin A status). The canonical recommendation is to prioritize dietary beta-carotene intake through colorful plant foods, to avoid standalone high-dose beta-carotene supplementation in current and former smokers, and to use moderate doses (3-10 mg daily) within mixed carotenoid formulations when supplementation is desired in non-smokers.", "lastReviewed": "2026-09-03T08:36:01.171Z", "url": "https://www.bodyhackguide.co/compound/beta-carotene", "author": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "reviewedBy": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "publisher": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" }, "mainContentOfPage": { "@type": "WebPageElement", "cssSelector": "main" }, "about": { "@type": "Drug", "name": "Beta-carotene", "alternateName": [ "Beta-carotene", "beta,beta-Carotene", "all-trans-beta-carotene", "9-cis-beta-carotene", "15-cis-beta-carotene", "Provitamin A", "Carotene", "Natural beta-carotene", "Synthetic beta-carotene", "Dunaliella salina extract", "Mixed carotenoids", "Food orange 5", "E160a", "BetaTene", "CaroCare" ], "description": "Beta-carotene is the most prominent provitamin A carotenoid and one of the most-studied dietary pigments in human nutrition. Chemically it is (all-E)-beta,beta-carotene — two symmetric beta-ionone rings connected by a central 18-carbon polyene chain with 11 conjugated double bonds. This symmetric bicyclic structure, with identical beta-ionone rings at both ends, distinguishes beta-carotene from its close dietary relatives: alpha-carotene has one beta-ring and one epsilon-ring; gamma-carotene has one beta-ring and an open-chain end; lycopene is fully acyclic with both ends as open isoprenoid chains; lutein and zeaxanthin are the hydroxylated xanthophyll counterparts. Only provitamin A carotenoids with at least one unsubstituted beta-ionone ring can be enzymatically cleaved to retinal (vitamin A) by the human enzyme beta-carotene 15,15'-oxygenase 1 (BCO1); beta-carotene has two such rings and is the most efficient dietary source of vitamin A among carotenoids. The dual role as an antioxidant and as a vitamin A precursor makes beta-carotene distinct from other dietary carotenoids. Unlike lycopene (no vitamin A activity), lutein and zeaxanthin (no vitamin A activity, eye-specific concentration), and astaxanthin (no vitamin A activity, systemic xanthophyll), beta-carotene contributes to vitamin A status in populations where preformed vitamin A intake is low. This is the primary nutritional rationale for beta-carotene fortification of food and for its use in vitamin A deficiency prevention programs in developing countries, particularly through Golden Rice and food fortification in sub-Saharan Africa and South Asia. Historical vitamin A intake, assessed in retinol activity equivalents (RAE), treats beta-carotene as contributing 1 RAE per 12 mcg of dietary beta-carotene (or 1 RAE per 24 mcg of other provitamin A carotenoids). This conversion reflects typical BCO1 cleavage efficiency in mixed dietary matrix and is substantially less efficient than preformed vitamin A from animal sources. The evidence landscape for beta-carotene supplementation underwent a major rethink following two landmark trials published in 1996. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC Study Group 1994, 1996) in 29,133 Finnish male smokers found that beta-carotene 20 mg daily increased lung cancer incidence by 18% and total mortality by 8%. The Beta-Carotene and Retinol Efficacy Trial (CARET, Omenn 1996 NEJM PMID 8602180) in 18,314 heavy smokers and asbestos-exposed workers found that beta-carotene 30 mg plus retinol 25,000 IU daily increased lung cancer incidence by 28% and total mortality by 17%, leading to early termination of the trial. The Physicians' Health Study (Hennekens 1996 NEJM PMID 8602179) in 22,071 predominantly non-smoking male physicians found that beta-carotene 50 mg every other day for 12 years had no effect on cancer or cardiovascular disease, providing reassurance that the smoker-specific signal did not extend to non-smokers. These trials transformed beta-carotene from a promising chemopreventive agent into a supplement with specific contraindication in smokers and former smokers. The AREDS2 trial (Chew 2013 JAMA PMID 23644932) replaced beta-carotene with lutein plus zeaxanthin in the second-generation AREDS formulation specifically because of the smoker safety concern. Current expert recommendations universally discourage isolated high-dose beta-carotene supplementation in current or former smokers, while dietary beta-carotene through food (carrots, sweet potatoes, pumpkin, leafy greens) is considered safe and beneficial in all populations. For non-smoking adults, beta-carotene remains a valid supplementation option within a multi-carotenoid stack, particularly for vitamin A status support in populations with low preformed vitamin A intake, for skin photoprotection, and for general antioxidant coverage. Dietary sources of beta-carotene are abundant: carrots contain 8-12 mg per 100 g, sweet potatoes 6-12 mg, kale 9 mg, spinach 5-6 mg, pumpkin 3-5 mg, apricots and mangoes 1-2 mg, cantaloupe 2-3 mg. A typical Western diet provides 2-5 mg of beta-carotene daily from these sources. Supplemental doses range from 3 mg (typical multivitamin) to 25 mg (standalone beta-carotene or mixed carotenoid formulations). Commercial beta-carotene for supplementation is produced by three routes: extraction from the microalga Dunaliella salina (natural 9-cis and all-trans isomer mixture, richest in 9-cis-beta-carotene which is not present in synthetic preparations), extraction from Blakeslea trispora fungal fermentation, and chemical synthesis (all-trans isomer only, historically used in CARET and ATBC). The Dunaliella-derived natural beta-carotene (BetaTene, Lyc-O-Beta natural, BASF natural beta-carotene) is often preferred because natural isomer mixtures have different bioavailability and tissue distribution compared to purely synthetic all-trans material, and because the natural preparation includes accompanying carotenoids (alpha-carotene, zeaxanthin traces) and tocopherols that may modulate the oxidative chemistry in more physiologic ways. Notably, the ATBC and CARET trials used synthetic all-trans-beta-carotene, and whether natural Dunaliella-derived beta-carotene would have produced the same smoker signal has been debated without definitive resolution; conservative practice treats natural and synthetic equivalently for the smoker contraindication. For bodyhackguide.co users, beta-carotene occupies a specific place in the nutritional landscape: vitamin A status support in vegetarian/vegan populations with limited preformed vitamin A intake, skin photoprotection when combined with other carotenoids, and general antioxidant stacking for non-smokers. It pairs with lutein and zeaxanthin (eye-specific xanthophylls without vitamin A activity), lycopene (prostate/cardiovascular acyclic carotenoid), astaxanthin (systemic xanthophyll), vitamin-e (membrane antioxidant synergism), and preformed vitamin-a (retinyl palmitate for populations needing guaranteed vitamin A status). The canonical recommendation is to prioritize dietary beta-carotene intake through colorful plant foods, to avoid standalone high-dose beta-carotene supplementation in current and former smokers, and to use moderate doses (3-10 mg daily) within mixed carotenoid formulations when supplementation is desired in non-smokers.", "activeIngredient": "Beta-carotene", "mechanismOfAction": "Beta-carotene acts through three interrelated mechanism clusters: provitamin A activity through enzymatic cleavage to retinal, direct antioxidant function through singlet oxygen quenching and radical scavenging, and modulation of gene expression through both retinoic acid-dependent and retinoic acid-independent pathways. The first mechanism cluster is provitamin A activity. Beta-carotene is absorbed intact at the intestinal brush border through the scavenger receptor B1 (SR-B1) facilitated transport, incorporated into chylomicrons, and either cleaved within enterocytes or delivered to peripheral tissues intact. The intestinal cleavage occurs primarily via BCO1 (beta-carotene 15,15'-oxygenase 1), which makes a central symmetric cleavage at the 15-15' double bond producing two molecules of all-trans-retinal per molecule of beta-carotene. In practice, the stoichiometry is less efficient than theoretical: typical human intestinal conversion produces approximately 1 mcg retinol activity equivalent (RAE) per 12 mcg of dietary beta-carotene in mixed food matrices, reflecting incomplete cleavage and variable bioavailability. BCO1 activity is regulated by dietary retinoic acid through a negative feedback loop: when vitamin A status is adequate, intestinal BCO1 activity decreases and absorbed beta-carotene is preferentially left intact for tissue distribution rather than cleaved. A secondary cleavage pathway involves BCO2 (beta-carotene 9',10'-oxygenase 2), which makes an eccentric cleavage at the 9'-10' double bond producing beta-ionone and beta-apo-10'-carotenal. BCO2 is expressed in mitochondria and acts on cis-isomers and on carotenoids that are less efficient BCO1 substrates. This eccentric cleavage pathway produces apo-carotenoid metabolites that have their own biological activity, independent of retinoic acid formation. Individual BCO1 polymorphisms substantially affect beta-carotene to retinol conversion. The BCO1 R267S and A379V variants reduce enzymatic activity by 40-50% in carriers, and approximately 45% of the general population carries at least one reduced-activity allele. For these individuals, beta-carotene is a less reliable source of vitamin A and preformed retinyl palmitate is preferred for guaranteed vitamin A status. The second mechanism cluster is direct antioxidant function. Beta-carotene is a potent singlet oxygen quencher, though less efficient than lycopene (rate constant approximately 14 x 10^9 M-1 s-1 for beta-carotene versus 31 x 10^9 for lycopene per Di Mascio 1989). The quenching mechanism is physical: beta-carotene's extended 11-double-bond conjugated system absorbs the excitation energy of singlet oxygen and dissipates it as heat. Beta-carotene also scavenges peroxyl radicals (ROO•) and other reactive oxygen species through a combination of radical addition, electron transfer, and hydrogen atom transfer reactions. However, beta-carotene shows a complex relationship with oxygen tension and other antioxidant cofactors that produces context-dependent behavior. Under low oxygen tension (hypoxic tissues, typical arterial blood), beta-carotene efficiently scavenges radicals and reduces oxidative damage. Under high oxygen tension (lung tissue, particularly in smokers whose lung epithelium is chronically exposed to high oxygen and oxidative stress from cigarette smoke), beta-carotene can exhibit pro-oxidant behavior because its radical intermediates are stabilized and propagate lipid peroxidation rather than terminating it. Burton and Ingold 1984originally described this oxygen-tension-dependent behavior of beta-carotene, and it provides the biochemical explanation for the CARET and ATBC smoker lung cancer signal. Additionally, the eccentric cleavage products of beta-carotene (beta-apo-carotenals, beta-apo-carotenoic acids) can be electrophilic and can modify DNA and protein targets. In smoker lung tissue with high BCO2 activity and oxidative environment, accumulation of these electrophilic metabolites may contribute to carcinogenesis. Wang 1999 and Russell 2004 reviewed the mechanistic hypotheses for the smoker signal and argued that pro-oxidant eccentric cleavage products are the most plausible molecular explanation. The third mechanism cluster is gene expression modulation. Retinoic acid — formed from beta-carotene-derived retinal via retinaldehyde dehydrogenases — is a potent transcriptional regulator acting through the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families of nuclear receptors. RAR-RXR heterodimers and RXR-RXR homodimers regulate hundreds of genes involved in cellular differentiation, proliferation, apoptosis, immune function, epithelial maintenance, and embryonic development. Retinoic acid-dependent gene expression is responsible for the broad effects of vitamin A on epithelial integrity, immune function, night vision (through visual cycle regeneration), and reproductive biology. Beyond retinoic acid, beta-carotene and its direct metabolites may modulate gene expression through retinoic acid-independent pathways. Apo-carotenoids activate and inhibit various transcription factors including PPARs, NF-kB, and Nrf2. The Nrf2-mediated antioxidant response element pathway is activated by oxidized carotenoid metabolites and amplifies endogenous antioxidant defense through induction of HO-1, NQO1, and glutathione-related enzymes. Beta-carotene's membrane behavior differs from that of xanthophylls. Beta-carotene is a non-polar carotene that does not span membranes with hydroxyl anchors but instead localizes within the hydrophobic core of lipid bilayers and lipoproteins. This gives it access to polyunsaturated fatty acids for lipid peroxidation protection but limits its ability to span biological membranes or interact with polar cellular compartments. The behavior is well-suited to LDL incorporation — beta-carotene is a significant antioxidant constituent of LDL particles and contributes to LDL oxidation resistance. Pharmacokinetically beta-carotene has a plasma half-life of approximately 7-10 days and tissue half-life of weeks in adipose and liver. Plasma levels rise over 4-8 weeks of supplementation and plateau at 8-12 weeks. Absorption is highly dependent on dietary fat — absorption from a fat-free meal can be near zero, while absorption with adequate dietary fat ranges from 10-30%. Tissue distribution emphasizes liver (the major storage organ, accounting for 70-90% of total body beta-carotene), adipose tissue, adrenal glands, testes, and skin. Skin accumulation contributes to skin coloration and photoprotection. Beta-carotene conversion to vitamin A is saturable. At high intakes (above 20-30 mg daily), intestinal BCO1 downregulates and the absorbed beta-carotene accumulates in plasma and peripheral tissues rather than converting to retinol. This is why beta-carotene does not produce vitamin A toxicity (hypervitaminosis A) at high doses — the body simply stops converting and stores the excess beta-carotene in tissues (manifesting as carotenodermia if intake is very high). This saturable conversion is a key safety feature distinguishing beta-carotene from preformed retinyl palmitate, where high doses produce hepatic toxicity and teratogenicity. A notable functional distinction between natural Dunaliella-derived beta-carotene and synthetic beta-carotene is isomer composition. Natural Dunaliella contains a mixture of approximately 50% 9-cis-beta-carotene and 50% all-trans-beta-carotene, plus accompanying alpha-carotene, zeaxanthin traces, and phytoene. Synthetic beta-carotene (as used in CARET and ATBC) is essentially 100% all-trans-beta-carotene. 9-cis-beta-carotene has different tissue distribution, slower hepatic elimination, and different effects on gene expression compared to the all-trans isomer. Whether 9-cis-enriched natural beta-carotene would produce the same smoker lung cancer signal as synthetic all-trans-beta-carotene has been debated without definitive resolution.", "legalStatus": "Not approved for human use — research chemical", "warning": "For research purposes only. Not for human consumption." } }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Why is beta-carotene dangerous for smokers?", "acceptedAnswer": { "@type": "Answer", "text": "Two landmark trials established that high-dose beta-carotene supplementation increases lung cancer risk in heavy smokers. The ATBC trial (1994) in 29,133 Finnish male smokers found 20 mg daily beta-carotene increased lung cancer incidence by 18%. The CARET trial (Omenn 1996 NEJM PMID 8602180) in 18,314 heavy smokers and asbestos workers found 30 mg plus retinol 25,000 IU daily increased lung cancer by 28% and was terminated early. The proposed mechanism involves pro-oxidant eccentric cleavage of beta-carotene in high-oxygen smoker lung tissue, producing reactive aldehyde metabolites that contribute to carcinogenesis. Dietary beta-carotene through food (carrots, sweet potatoes, greens) has not shown this signal and remains safe for smokers; the problem is isolated high-dose supplementation only. Former smokers are typically advised to avoid high-dose supplementation for at least 15 years after quitting." } }, { "@type": "Question", "name": "Is dietary beta-carotene safe for smokers?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. The CARET and ATBC trials used synthetic beta-carotene pills at 20-30 mg daily. Dietary intake through food provides comparable doses but with very different pharmacokinetics — slower absorption, presence of accompanying phytonutrients, and tissue distribution that does not replicate the harmful signal. Observational studies consistently show that dietary fruit and vegetable consumption is associated with lower cancer risk, including in smokers. Smokers should continue to eat carrots, sweet potatoes, spinach, pumpkin, and other beta-carotene-rich foods; only isolated high-dose supplementation (20 mg daily or more) is contraindicated. Small amounts of beta-carotene in standard multivitamins (1-3 mg) are generally considered acceptable." } }, { "@type": "Question", "name": "Is natural Dunaliella-derived beta-carotene safer than synthetic?", "acceptedAnswer": { "@type": "Answer", "text": "Possibly, but not definitively established. The CARET and ATBC trials used synthetic all-trans-beta-carotene, not natural Dunaliella-derived beta-carotene. Natural Dunaliella contains approximately 50% 9-cis-beta-carotene (absent from synthetic preparations) plus accompanying carotenoids and tocopherols. Some researchers have argued that the 9-cis form and accompanying phytonutrients may produce different (potentially safer) oxidative chemistry than pure all-trans synthetic beta-carotene. However, no randomized trial has directly compared natural versus synthetic beta-carotene in smokers for lung cancer outcomes, and the conservative clinical recommendation is to treat all beta-carotene supplementation forms equivalently for the smoker contraindication. Natural Dunaliella is preferred over synthetic in non-smokers for general quality and phytonutrient diversity reasons." } }, { "@type": "Question", "name": "Should I take beta-carotene for vitamin A?", "acceptedAnswer": { "@type": "Answer", "text": "It depends on your vitamin A status, BCO1 genotype, and preformed vitamin A intake. Beta-carotene is the safer source of vitamin A than preformed retinyl palmitate because it cannot cause hypervitaminosis A or teratogenicity — intestinal conversion to retinal is saturable. However, BCO1 polymorphisms (R267S, A379V) reduce conversion efficiency by 40-50% in approximately 45% of the population, making beta-carotene less reliable for those carriers. Vegans, strict vegetarians, and people with limited animal food intake benefit from beta-carotene contribution to vitamin A status. Those with adequate preformed vitamin A intake (eggs, dairy, fish, liver) typically don't need additional beta-carotene for vitamin A status. Preformed vitamin A from a prenatal or high-quality multivitamin (2500-5000 IU) provides guaranteed vitamin A status without conversion uncertainty." } }, { "@type": "Question", "name": "What happens if I take too much beta-carotene?", "acceptedAnswer": { "@type": "Answer", "text": "The most common effect of high-dose intake is carotenodermia — a yellow-orange pigmentation of the skin, particularly visible on the palms, soles, and nasolabial folds. Carotenodermia occurs at sustained intakes above 20-30 mg daily from all sources (food plus supplements) and is completely reversible within 2-6 weeks of reduced intake. Unlike jaundice, carotenodermia does not affect the sclera of the eyes (eyes remain white). Beta-carotene cannot cause hypervitaminosis A because conversion to retinol is saturable — your body stops converting when vitamin A status is adequate. No hepatotoxicity. No teratogenicity. The only clinically significant concern at high doses is the smoker lung cancer signal; non-smokers taking 25-50 mg daily for skin photoprotection or EPP therapy do not show clinical toxicity aside from cosmetic carotenodermia." } }, { "@type": "Question", "name": "Why did AREDS2 remove beta-carotene from the eye health formula?", "acceptedAnswer": { "@type": "Answer", "text": "Because of the smoker lung cancer safety signal from CARET and ATBC. The original AREDS trial (2001) included beta-carotene 15 mg daily as part of the AMD prevention formulation, but by the time AREDS2 was designed it was clear that beta-carotene should be avoided in any population including smokers. AREDS2 tested whether lutein 10 mg plus zeaxanthin 2 mg could replace beta-carotene while maintaining AMD prevention benefit — the answer was yes, with non-inferior AMD outcomes and superior safety in former smokers. AREDS2 is now the evidence-based standard, and any eye health formulation sold today for AMD prevention should use lutein plus zeaxanthin rather than beta-carotene. Patients with any smoking history should only use AREDS2-style formulations." } }, { "@type": "Question", "name": "Can I take beta-carotene during pregnancy?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, at appropriate doses. Dietary beta-carotene through carrots, sweet potatoes, spinach, and other colorful vegetables is safe and encouraged during pregnancy. Supplemental beta-carotene at doses up to 25,000 IU (15 mg) daily within a prenatal multivitamin is safe — actually preferred over preformed retinyl palmitate because beta-carotene cannot cause teratogenic hypervitaminosis A. The retinol teratogenicity threshold (approximately 10,000 IU daily of preformed vitamin A) does not apply to beta-carotene. Very high-dose beta-carotene supplementation (25+ mg daily) during pregnancy has not been well-studied and should be avoided unless medically indicated. Most prenatal vitamins use beta-carotene as the primary vitamin A source for this safety reason." } }, { "@type": "Question", "name": "Does beta-carotene help with skin sun protection?", "acceptedAnswer": { "@type": "Answer", "text": "Modestly, yes, in non-smokers. Studies by Mathews-Roth in the 1970s and more recent work by Heinrich 2003 have shown that beta-carotene 15-30 mg daily for several months increases minimal erythema dose (the UV exposure threshold for visible skin erythema) by 20-40%. The effect is cumulative over weeks to months, not acute. Mechanism involves beta-carotene accumulation in skin, direct UV photon absorption, and singlet oxygen quenching of UV-induced ROS. The oral photoprotection effect is modest (equivalent to roughly SPF 1-2) and does NOT replace topical sunscreen for sun protection. Lycopene and astaxanthin provide similar or stronger oral photoprotection and are preferred in smokers; for non-smokers, combining beta-carotene with other carotenoids provides best-case oral photoprotection." } }, { "@type": "Question", "name": "What are the best food sources of beta-carotene?", "acceptedAnswer": { "@type": "Answer", "text": "Orange and deep green vegetables are richest. Sweet potatoes (cooked, 12 mg per medium), carrots (6-8 mg per medium raw), kale (9 mg per cup cooked), spinach (11 mg per cup cooked), pumpkin (7 mg per cup cooked), butternut squash (9 mg per cup cooked), cantaloupe (7 mg per half), mango (2 mg per medium), and apricots (0.5 mg each) are the major dietary sources. Tomatoes and red peppers contain modest beta-carotene alongside their higher lycopene or lutein content. For maximum absorption, cook with fat (olive oil, butter, or ghee) — beta-carotene absorption from a fat-free meal can be near zero, while absorption with adequate dietary fat ranges from 10-30%. A typical Western diet provides 2-5 mg daily; adding one sweet potato serving or large kale salad daily easily achieves 10-15 mg dietary intake, meeting or exceeding typical supplementation doses." } }, { "@type": "Question", "name": "Should I take beta-carotene or a mixed carotenoid formulation?", "acceptedAnswer": { "@type": "Answer", "text": "Mixed carotenoid formulations are generally preferred for non-smokers seeking general supplementation. Different carotenoids concentrate in different tissues (lycopene in prostate and skin, lutein/zeaxanthin in eyes, astaxanthin systemically, beta-carotene in liver and skin) and provide complementary rather than redundant protection. A formulation providing beta-carotene 5 mg, alpha-carotene 1 mg, lutein 10 mg, zeaxanthin 2 mg, and lycopene 10 mg delivers better tissue coverage than standalone high-dose beta-carotene. For skin photoprotection specifically, astaxanthin 4-8 mg and lycopene 10-20 mg have better evidence than beta-carotene alone. For eye health specifically, lutein plus zeaxanthin is the AREDS2-validated formulation. Isolated beta-carotene supplementation at high doses is indicated only for erythropoietic protoporphyria therapy or vitamin A deficiency correction in specific populations. Dietary diversity of colorful fruits and vegetables provides the most robust multi-carotenoid intake." } } ] }, { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.bodyhackguide.co#organization", "name": "BodyHackGuide", "alternateName": "BHG", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/logo.png", "width": 512, "height": 512 }, "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, real-time vendor pricing, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. BodyHackGuide and BHG Labs share common ownership, and we earn a commission on purchases through our links.", "foundingDate": "2024", "founder": { "@id": "https://www.bodyhackguide.co/about#person" }, "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher", "https://discord.gg/Mhq5UdRYBA" ], "knowsAbout": [ "Peptide research", "Nootropic research", "Biohacking", "Compound dosing", "Vendor transparency" ], "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards", "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards", "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards" }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "Beta-carotene", "description": "Beta-carotene is the most prominent provitamin A carotenoid and one of the most-studied dietary pigments in human nutrition. Chemically it is (all-E)-beta,beta-carotene — two symmetric beta-ionone rings connected by a central 18-carbon polyene chain with 11 conjugated double bonds. This symmetric bicyclic structure, with identical beta-ionone rings at both ends, distinguishes beta-carotene from its close dietary relatives: alpha-carotene has one beta-ring and one epsilon-ring; gamma-carotene has one beta-ring and an open-chain end; lycopene is fully acyclic with both ends as open isoprenoid chains; lutein and zeaxanthin are the hydroxylated xanthophyll counterparts. Only provitamin A carotenoids with at least one unsubstituted beta-ionone ring can be enzymatically cleaved to retinal (vitamin A) by the human enzyme beta-carotene 15,15'-oxygenase 1 (BCO1); beta-carotene has two such rings and is the most efficient dietary source of vitamin A among carotenoids. The dual role as an antioxidant and as a vitamin A precursor makes beta-carotene distinct from other dietary carotenoids. Unlike lycopene (no vitamin A activity), lutein and zeaxanthin (no vitamin A activity, eye-specific concentration), and astaxanthin (no vitamin A activity, systemic xanthophyll), beta-carotene contributes to vitamin A status in populations where preformed vitamin A intake is low. This is the primary nutritional rationale for beta-carotene fortification of food and for its use in vitamin A deficiency prevention programs in developing countries, particularly through Golden Rice and food fortification in sub-Saharan Africa and South Asia. Historical vitamin A intake, assessed in retinol activity equivalents (RAE), treats beta-carotene as contributing 1 RAE per 12 mcg of dietary beta-carotene (or 1 RAE per 24 mcg of other provitamin A carotenoids). This conversion reflects typical BCO1 cleavage efficiency in mixed dietary matrix and is substantially less efficient than preformed vitamin A from animal sources. The evidence landscape for beta-carotene supplementation underwent a major rethink following two landmark trials published in 1996. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC Study Group 1994, 1996) in 29,133 Finnish male smokers found that beta-carotene 20 mg daily increased lung cancer incidence by 18% and total mortality by 8%. The Beta-Carotene and Retinol Efficacy Trial (CARET, Omenn 1996 NEJM PMID 8602180) in 18,314 heavy smokers and asbestos-exposed workers found that beta-carotene 30 mg plus retinol 25,000 IU daily increased lung cancer incidence by 28% and total mortality by 17%, leading to early termination of the trial. The Physicians' Health Study (Hennekens 1996 NEJM PMID 8602179) in 22,071 predominantly non-smoking male physicians found that beta-carotene 50 mg every other day for 12 years had no effect on cancer or cardiovascular disease, providing reassurance that the smoker-specific signal did not extend to non-smokers. These trials transformed beta-carotene from a promising chemopreventive agent into a supplement with specific contraindication in smokers and former smokers. The AREDS2 trial (Chew 2013 JAMA PMID 23644932) replaced beta-carotene with lutein plus zeaxanthin in the second-generation AREDS formulation specifically because of the smoker safety concern. Current expert recommendations universally discourage isolated high-dose beta-carotene supplementation in current or former smokers, while dietary beta-carotene through food (carrots, sweet potatoes, pumpkin, leafy greens) is considered safe and beneficial in all populations. For non-smoking adults, beta-carotene remains a valid supplementation option within a multi-carotenoid stack, particularly for vitamin A status support in populations with low preformed vitamin A intake, for skin photoprotection, and for general antioxidant coverage. Dietary sources of beta-carotene are abundant: carrots contain 8-12 mg per 100 g, sweet potatoes 6-12 mg, kale 9 mg, spinach 5-6 mg, pumpkin 3-5 mg, apricots and mangoes 1-2 mg, cantaloupe 2-3 mg. A typical Western diet provides 2-5 mg of beta-carotene daily from these sources. Supplemental doses range from 3 mg (typical multivitamin) to 25 mg (standalone beta-carotene or mixed carotenoid formulations). Commercial beta-carotene for supplementation is produced by three routes: extraction from the microalga Dunaliella salina (natural 9-cis and all-trans isomer mixture, richest in 9-cis-beta-carotene which is not present in synthetic preparations), extraction from Blakeslea trispora fungal fermentation, and chemical synthesis (all-trans isomer only, historically used in CARET and ATBC). The Dunaliella-derived natural beta-carotene (BetaTene, Lyc-O-Beta natural, BASF natural beta-carotene) is often preferred because natural isomer mixtures have different bioavailability and tissue distribution compared to purely synthetic all-trans material, and because the natural preparation includes accompanying carotenoids (alpha-carotene, zeaxanthin traces) and tocopherols that may modulate the oxidative chemistry in more physiologic ways. Notably, the ATBC and CARET trials used synthetic all-trans-beta-carotene, and whether natural Dunaliella-derived beta-carotene would have produced the same smoker signal has been debated without definitive resolution; conservative practice treats natural and synthetic equivalently for the smoker contraindication. For bodyhackguide.co users, beta-carotene occupies a specific place in the nutritional landscape: vitamin A status support in vegetarian/vegan populations with limited preformed vitamin A intake, skin photoprotection when combined with other carotenoids, and general antioxidant stacking for non-smokers. It pairs with lutein and zeaxanthin (eye-specific xanthophylls without vitamin A activity), lycopene (prostate/cardiovascular acyclic carotenoid), astaxanthin (systemic xanthophyll), vitamin-e (membrane antioxidant synergism), and preformed vitamin-a (retinyl palmitate for populations needing guaranteed vitamin A status). The canonical recommendation is to prioritize dietary beta-carotene intake through colorful plant foods, to avoid standalone high-dose beta-carotene supplementation in current and former smokers, and to use moderate doses (3-10 mg daily) within mixed carotenoid formulations when supplementation is desired in non-smokers.", "lastReviewed": "2026-09-03T08:36:01.171Z", "url": "https://www.bodyhackguide.co/compound/beta-carotene", "author": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "reviewedBy": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "publisher": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" }, "mainContentOfPage": { "@type": "WebPageElement", "cssSelector": "main" }, "about": { "@type": "Drug", "name": "Beta-carotene", "alternateName": [ "Beta-carotene", "beta,beta-Carotene", "all-trans-beta-carotene", "9-cis-beta-carotene", "15-cis-beta-carotene", "Provitamin A", "Carotene", "Natural beta-carotene", "Synthetic beta-carotene", "Dunaliella salina extract", "Mixed carotenoids", "Food orange 5", "E160a", "BetaTene", "CaroCare" ], "description": "Beta-carotene is the most prominent provitamin A carotenoid and one of the most-studied dietary pigments in human nutrition. Chemically it is (all-E)-beta,beta-carotene — two symmetric beta-ionone rings connected by a central 18-carbon polyene chain with 11 conjugated double bonds. This symmetric bicyclic structure, with identical beta-ionone rings at both ends, distinguishes beta-carotene from its close dietary relatives: alpha-carotene has one beta-ring and one epsilon-ring; gamma-carotene has one beta-ring and an open-chain end; lycopene is fully acyclic with both ends as open isoprenoid chains; lutein and zeaxanthin are the hydroxylated xanthophyll counterparts. Only provitamin A carotenoids with at least one unsubstituted beta-ionone ring can be enzymatically cleaved to retinal (vitamin A) by the human enzyme beta-carotene 15,15'-oxygenase 1 (BCO1); beta-carotene has two such rings and is the most efficient dietary source of vitamin A among carotenoids. The dual role as an antioxidant and as a vitamin A precursor makes beta-carotene distinct from other dietary carotenoids. Unlike lycopene (no vitamin A activity), lutein and zeaxanthin (no vitamin A activity, eye-specific concentration), and astaxanthin (no vitamin A activity, systemic xanthophyll), beta-carotene contributes to vitamin A status in populations where preformed vitamin A intake is low. This is the primary nutritional rationale for beta-carotene fortification of food and for its use in vitamin A deficiency prevention programs in developing countries, particularly through Golden Rice and food fortification in sub-Saharan Africa and South Asia. Historical vitamin A intake, assessed in retinol activity equivalents (RAE), treats beta-carotene as contributing 1 RAE per 12 mcg of dietary beta-carotene (or 1 RAE per 24 mcg of other provitamin A carotenoids). This conversion reflects typical BCO1 cleavage efficiency in mixed dietary matrix and is substantially less efficient than preformed vitamin A from animal sources. The evidence landscape for beta-carotene supplementation underwent a major rethink following two landmark trials published in 1996. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC Study Group 1994, 1996) in 29,133 Finnish male smokers found that beta-carotene 20 mg daily increased lung cancer incidence by 18% and total mortality by 8%. The Beta-Carotene and Retinol Efficacy Trial (CARET, Omenn 1996 NEJM PMID 8602180) in 18,314 heavy smokers and asbestos-exposed workers found that beta-carotene 30 mg plus retinol 25,000 IU daily increased lung cancer incidence by 28% and total mortality by 17%, leading to early termination of the trial. The Physicians' Health Study (Hennekens 1996 NEJM PMID 8602179) in 22,071 predominantly non-smoking male physicians found that beta-carotene 50 mg every other day for 12 years had no effect on cancer or cardiovascular disease, providing reassurance that the smoker-specific signal did not extend to non-smokers. These trials transformed beta-carotene from a promising chemopreventive agent into a supplement with specific contraindication in smokers and former smokers. The AREDS2 trial (Chew 2013 JAMA PMID 23644932) replaced beta-carotene with lutein plus zeaxanthin in the second-generation AREDS formulation specifically because of the smoker safety concern. Current expert recommendations universally discourage isolated high-dose beta-carotene supplementation in current or former smokers, while dietary beta-carotene through food (carrots, sweet potatoes, pumpkin, leafy greens) is considered safe and beneficial in all populations. For non-smoking adults, beta-carotene remains a valid supplementation option within a multi-carotenoid stack, particularly for vitamin A status support in populations with low preformed vitamin A intake, for skin photoprotection, and for general antioxidant coverage. Dietary sources of beta-carotene are abundant: carrots contain 8-12 mg per 100 g, sweet potatoes 6-12 mg, kale 9 mg, spinach 5-6 mg, pumpkin 3-5 mg, apricots and mangoes 1-2 mg, cantaloupe 2-3 mg. A typical Western diet provides 2-5 mg of beta-carotene daily from these sources. Supplemental doses range from 3 mg (typical multivitamin) to 25 mg (standalone beta-carotene or mixed carotenoid formulations). Commercial beta-carotene for supplementation is produced by three routes: extraction from the microalga Dunaliella salina (natural 9-cis and all-trans isomer mixture, richest in 9-cis-beta-carotene which is not present in synthetic preparations), extraction from Blakeslea trispora fungal fermentation, and chemical synthesis (all-trans isomer only, historically used in CARET and ATBC). The Dunaliella-derived natural beta-carotene (BetaTene, Lyc-O-Beta natural, BASF natural beta-carotene) is often preferred because natural isomer mixtures have different bioavailability and tissue distribution compared to purely synthetic all-trans material, and because the natural preparation includes accompanying carotenoids (alpha-carotene, zeaxanthin traces) and tocopherols that may modulate the oxidative chemistry in more physiologic ways. Notably, the ATBC and CARET trials used synthetic all-trans-beta-carotene, and whether natural Dunaliella-derived beta-carotene would have produced the same smoker signal has been debated without definitive resolution; conservative practice treats natural and synthetic equivalently for the smoker contraindication. For bodyhackguide.co users, beta-carotene occupies a specific place in the nutritional landscape: vitamin A status support in vegetarian/vegan populations with limited preformed vitamin A intake, skin photoprotection when combined with other carotenoids, and general antioxidant stacking for non-smokers. It pairs with lutein and zeaxanthin (eye-specific xanthophylls without vitamin A activity), lycopene (prostate/cardiovascular acyclic carotenoid), astaxanthin (systemic xanthophyll), vitamin-e (membrane antioxidant synergism), and preformed vitamin-a (retinyl palmitate for populations needing guaranteed vitamin A status). The canonical recommendation is to prioritize dietary beta-carotene intake through colorful plant foods, to avoid standalone high-dose beta-carotene supplementation in current and former smokers, and to use moderate doses (3-10 mg daily) within mixed carotenoid formulations when supplementation is desired in non-smokers.", "activeIngredient": "Beta-carotene", "mechanismOfAction": "Beta-carotene acts through three interrelated mechanism clusters: provitamin A activity through enzymatic cleavage to retinal, direct antioxidant function through singlet oxygen quenching and radical scavenging, and modulation of gene expression through both retinoic acid-dependent and retinoic acid-independent pathways. The first mechanism cluster is provitamin A activity. Beta-carotene is absorbed intact at the intestinal brush border through the scavenger receptor B1 (SR-B1) facilitated transport, incorporated into chylomicrons, and either cleaved within enterocytes or delivered to peripheral tissues intact. The intestinal cleavage occurs primarily via BCO1 (beta-carotene 15,15'-oxygenase 1), which makes a central symmetric cleavage at the 15-15' double bond producing two molecules of all-trans-retinal per molecule of beta-carotene. In practice, the stoichiometry is less efficient than theoretical: typical human intestinal conversion produces approximately 1 mcg retinol activity equivalent (RAE) per 12 mcg of dietary beta-carotene in mixed food matrices, reflecting incomplete cleavage and variable bioavailability. BCO1 activity is regulated by dietary retinoic acid through a negative feedback loop: when vitamin A status is adequate, intestinal BCO1 activity decreases and absorbed beta-carotene is preferentially left intact for tissue distribution rather than cleaved. A secondary cleavage pathway involves BCO2 (beta-carotene 9',10'-oxygenase 2), which makes an eccentric cleavage at the 9'-10' double bond producing beta-ionone and beta-apo-10'-carotenal. BCO2 is expressed in mitochondria and acts on cis-isomers and on carotenoids that are less efficient BCO1 substrates. This eccentric cleavage pathway produces apo-carotenoid metabolites that have their own biological activity, independent of retinoic acid formation. Individual BCO1 polymorphisms substantially affect beta-carotene to retinol conversion. The BCO1 R267S and A379V variants reduce enzymatic activity by 40-50% in carriers, and approximately 45% of the general population carries at least one reduced-activity allele. For these individuals, beta-carotene is a less reliable source of vitamin A and preformed retinyl palmitate is preferred for guaranteed vitamin A status. The second mechanism cluster is direct antioxidant function. Beta-carotene is a potent singlet oxygen quencher, though less efficient than lycopene (rate constant approximately 14 x 10^9 M-1 s-1 for beta-carotene versus 31 x 10^9 for lycopene per Di Mascio 1989). The quenching mechanism is physical: beta-carotene's extended 11-double-bond conjugated system absorbs the excitation energy of singlet oxygen and dissipates it as heat. Beta-carotene also scavenges peroxyl radicals (ROO•) and other reactive oxygen species through a combination of radical addition, electron transfer, and hydrogen atom transfer reactions. However, beta-carotene shows a complex relationship with oxygen tension and other antioxidant cofactors that produces context-dependent behavior. Under low oxygen tension (hypoxic tissues, typical arterial blood), beta-carotene efficiently scavenges radicals and reduces oxidative damage. Under high oxygen tension (lung tissue, particularly in smokers whose lung epithelium is chronically exposed to high oxygen and oxidative stress from cigarette smoke), beta-carotene can exhibit pro-oxidant behavior because its radical intermediates are stabilized and propagate lipid peroxidation rather than terminating it. Burton and Ingold 1984originally described this oxygen-tension-dependent behavior of beta-carotene, and it provides the biochemical explanation for the CARET and ATBC smoker lung cancer signal. Additionally, the eccentric cleavage products of beta-carotene (beta-apo-carotenals, beta-apo-carotenoic acids) can be electrophilic and can modify DNA and protein targets. In smoker lung tissue with high BCO2 activity and oxidative environment, accumulation of these electrophilic metabolites may contribute to carcinogenesis. Wang 1999 and Russell 2004 reviewed the mechanistic hypotheses for the smoker signal and argued that pro-oxidant eccentric cleavage products are the most plausible molecular explanation. The third mechanism cluster is gene expression modulation. Retinoic acid — formed from beta-carotene-derived retinal via retinaldehyde dehydrogenases — is a potent transcriptional regulator acting through the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families of nuclear receptors. RAR-RXR heterodimers and RXR-RXR homodimers regulate hundreds of genes involved in cellular differentiation, proliferation, apoptosis, immune function, epithelial maintenance, and embryonic development. Retinoic acid-dependent gene expression is responsible for the broad effects of vitamin A on epithelial integrity, immune function, night vision (through visual cycle regeneration), and reproductive biology. Beyond retinoic acid, beta-carotene and its direct metabolites may modulate gene expression through retinoic acid-independent pathways. Apo-carotenoids activate and inhibit various transcription factors including PPARs, NF-kB, and Nrf2. The Nrf2-mediated antioxidant response element pathway is activated by oxidized carotenoid metabolites and amplifies endogenous antioxidant defense through induction of HO-1, NQO1, and glutathione-related enzymes. Beta-carotene's membrane behavior differs from that of xanthophylls. Beta-carotene is a non-polar carotene that does not span membranes with hydroxyl anchors but instead localizes within the hydrophobic core of lipid bilayers and lipoproteins. This gives it access to polyunsaturated fatty acids for lipid peroxidation protection but limits its ability to span biological membranes or interact with polar cellular compartments. The behavior is well-suited to LDL incorporation — beta-carotene is a significant antioxidant constituent of LDL particles and contributes to LDL oxidation resistance. Pharmacokinetically beta-carotene has a plasma half-life of approximately 7-10 days and tissue half-life of weeks in adipose and liver. Plasma levels rise over 4-8 weeks of supplementation and plateau at 8-12 weeks. Absorption is highly dependent on dietary fat — absorption from a fat-free meal can be near zero, while absorption with adequate dietary fat ranges from 10-30%. Tissue distribution emphasizes liver (the major storage organ, accounting for 70-90% of total body beta-carotene), adipose tissue, adrenal glands, testes, and skin. Skin accumulation contributes to skin coloration and photoprotection. Beta-carotene conversion to vitamin A is saturable. At high intakes (above 20-30 mg daily), intestinal BCO1 downregulates and the absorbed beta-carotene accumulates in plasma and peripheral tissues rather than converting to retinol. This is why beta-carotene does not produce vitamin A toxicity (hypervitaminosis A) at high doses — the body simply stops converting and stores the excess beta-carotene in tissues (manifesting as carotenodermia if intake is very high). This saturable conversion is a key safety feature distinguishing beta-carotene from preformed retinyl palmitate, where high doses produce hepatic toxicity and teratogenicity. A notable functional distinction between natural Dunaliella-derived beta-carotene and synthetic beta-carotene is isomer composition. Natural Dunaliella contains a mixture of approximately 50% 9-cis-beta-carotene and 50% all-trans-beta-carotene, plus accompanying alpha-carotene, zeaxanthin traces, and phytoene. Synthetic beta-carotene (as used in CARET and ATBC) is essentially 100% all-trans-beta-carotene. 9-cis-beta-carotene has different tissue distribution, slower hepatic elimination, and different effects on gene expression compared to the all-trans isomer. Whether 9-cis-enriched natural beta-carotene would produce the same smoker lung cancer signal as synthetic all-trans-beta-carotene has been debated without definitive resolution.", "legalStatus": "Not approved for human use — research chemical", "warning": "For research purposes only. Not for human consumption." } }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Why is beta-carotene dangerous for smokers?", "acceptedAnswer": { "@type": "Answer", "text": "Two landmark trials established that high-dose beta-carotene supplementation increases lung cancer risk in heavy smokers. The ATBC trial (1994) in 29,133 Finnish male smokers found 20 mg daily beta-carotene increased lung cancer incidence by 18%. The CARET trial (Omenn 1996 NEJM PMID 8602180) in 18,314 heavy smokers and asbestos workers found 30 mg plus retinol 25,000 IU daily increased lung cancer by 28% and was terminated early. The proposed mechanism involves pro-oxidant eccentric cleavage of beta-carotene in high-oxygen smoker lung tissue, producing reactive aldehyde metabolites that contribute to carcinogenesis. Dietary beta-carotene through food (carrots, sweet potatoes, greens) has not shown this signal and remains safe for smokers; the problem is isolated high-dose supplementation only. Former smokers are typically advised to avoid high-dose supplementation for at least 15 years after quitting." } }, { "@type": "Question", "name": "Is dietary beta-carotene safe for smokers?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. The CARET and ATBC trials used synthetic beta-carotene pills at 20-30 mg daily. Dietary intake through food provides comparable doses but with very different pharmacokinetics — slower absorption, presence of accompanying phytonutrients, and tissue distribution that does not replicate the harmful signal. Observational studies consistently show that dietary fruit and vegetable consumption is associated with lower cancer risk, including in smokers. Smokers should continue to eat carrots, sweet potatoes, spinach, pumpkin, and other beta-carotene-rich foods; only isolated high-dose supplementation (20 mg daily or more) is contraindicated. Small amounts of beta-carotene in standard multivitamins (1-3 mg) are generally considered acceptable." } }, { "@type": "Question", "name": "Is natural Dunaliella-derived beta-carotene safer than synthetic?", "acceptedAnswer": { "@type": "Answer", "text": "Possibly, but not definitively established. The CARET and ATBC trials used synthetic all-trans-beta-carotene, not natural Dunaliella-derived beta-carotene. Natural Dunaliella contains approximately 50% 9-cis-beta-carotene (absent from synthetic preparations) plus accompanying carotenoids and tocopherols. Some researchers have argued that the 9-cis form and accompanying phytonutrients may produce different (potentially safer) oxidative chemistry than pure all-trans synthetic beta-carotene. However, no randomized trial has directly compared natural versus synthetic beta-carotene in smokers for lung cancer outcomes, and the conservative clinical recommendation is to treat all beta-carotene supplementation forms equivalently for the smoker contraindication. Natural Dunaliella is preferred over synthetic in non-smokers for general quality and phytonutrient diversity reasons." } }, { "@type": "Question", "name": "Should I take beta-carotene for vitamin A?", "acceptedAnswer": { "@type": "Answer", "text": "It depends on your vitamin A status, BCO1 genotype, and preformed vitamin A intake. Beta-carotene is the safer source of vitamin A than preformed retinyl palmitate because it cannot cause hypervitaminosis A or teratogenicity — intestinal conversion to retinal is saturable. However, BCO1 polymorphisms (R267S, A379V) reduce conversion efficiency by 40-50% in approximately 45% of the population, making beta-carotene less reliable for those carriers. Vegans, strict vegetarians, and people with limited animal food intake benefit from beta-carotene contribution to vitamin A status. Those with adequate preformed vitamin A intake (eggs, dairy, fish, liver) typically don't need additional beta-carotene for vitamin A status. Preformed vitamin A from a prenatal or high-quality multivitamin (2500-5000 IU) provides guaranteed vitamin A status without conversion uncertainty." } }, { "@type": "Question", "name": "What happens if I take too much beta-carotene?", "acceptedAnswer": { "@type": "Answer", "text": "The most common effect of high-dose intake is carotenodermia — a yellow-orange pigmentation of the skin, particularly visible on the palms, soles, and nasolabial folds. Carotenodermia occurs at sustained intakes above 20-30 mg daily from all sources (food plus supplements) and is completely reversible within 2-6 weeks of reduced intake. Unlike jaundice, carotenodermia does not affect the sclera of the eyes (eyes remain white). Beta-carotene cannot cause hypervitaminosis A because conversion to retinol is saturable — your body stops converting when vitamin A status is adequate. No hepatotoxicity. No teratogenicity. The only clinically significant concern at high doses is the smoker lung cancer signal; non-smokers taking 25-50 mg daily for skin photoprotection or EPP therapy do not show clinical toxicity aside from cosmetic carotenodermia." } }, { "@type": "Question", "name": "Why did AREDS2 remove beta-carotene from the eye health formula?", "acceptedAnswer": { "@type": "Answer", "text": "Because of the smoker lung cancer safety signal from CARET and ATBC. The original AREDS trial (2001) included beta-carotene 15 mg daily as part of the AMD prevention formulation, but by the time AREDS2 was designed it was clear that beta-carotene should be avoided in any population including smokers. AREDS2 tested whether lutein 10 mg plus zeaxanthin 2 mg could replace beta-carotene while maintaining AMD prevention benefit — the answer was yes, with non-inferior AMD outcomes and superior safety in former smokers. AREDS2 is now the evidence-based standard, and any eye health formulation sold today for AMD prevention should use lutein plus zeaxanthin rather than beta-carotene. Patients with any smoking history should only use AREDS2-style formulations." } }, { "@type": "Question", "name": "Can I take beta-carotene during pregnancy?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, at appropriate doses. Dietary beta-carotene through carrots, sweet potatoes, spinach, and other colorful vegetables is safe and encouraged during pregnancy. Supplemental beta-carotene at doses up to 25,000 IU (15 mg) daily within a prenatal multivitamin is safe — actually preferred over preformed retinyl palmitate because beta-carotene cannot cause teratogenic hypervitaminosis A. The retinol teratogenicity threshold (approximately 10,000 IU daily of preformed vitamin A) does not apply to beta-carotene. Very high-dose beta-carotene supplementation (25+ mg daily) during pregnancy has not been well-studied and should be avoided unless medically indicated. Most prenatal vitamins use beta-carotene as the primary vitamin A source for this safety reason." } }, { "@type": "Question", "name": "Does beta-carotene help with skin sun protection?", "acceptedAnswer": { "@type": "Answer", "text": "Modestly, yes, in non-smokers. Studies by Mathews-Roth in the 1970s and more recent work by Heinrich 2003 have shown that beta-carotene 15-30 mg daily for several months increases minimal erythema dose (the UV exposure threshold for visible skin erythema) by 20-40%. The effect is cumulative over weeks to months, not acute. Mechanism involves beta-carotene accumulation in skin, direct UV photon absorption, and singlet oxygen quenching of UV-induced ROS. The oral photoprotection effect is modest (equivalent to roughly SPF 1-2) and does NOT replace topical sunscreen for sun protection. Lycopene and astaxanthin provide similar or stronger oral photoprotection and are preferred in smokers; for non-smokers, combining beta-carotene with other carotenoids provides best-case oral photoprotection." } }, { "@type": "Question", "name": "What are the best food sources of beta-carotene?", "acceptedAnswer": { "@type": "Answer", "text": "Orange and deep green vegetables are richest. Sweet potatoes (cooked, 12 mg per medium), carrots (6-8 mg per medium raw), kale (9 mg per cup cooked), spinach (11 mg per cup cooked), pumpkin (7 mg per cup cooked), butternut squash (9 mg per cup cooked), cantaloupe (7 mg per half), mango (2 mg per medium), and apricots (0.5 mg each) are the major dietary sources. Tomatoes and red peppers contain modest beta-carotene alongside their higher lycopene or lutein content. For maximum absorption, cook with fat (olive oil, butter, or ghee) — beta-carotene absorption from a fat-free meal can be near zero, while absorption with adequate dietary fat ranges from 10-30%. A typical Western diet provides 2-5 mg daily; adding one sweet potato serving or large kale salad daily easily achieves 10-15 mg dietary intake, meeting or exceeding typical supplementation doses." } }, { "@type": "Question", "name": "Should I take beta-carotene or a mixed carotenoid formulation?", "acceptedAnswer": { "@type": "Answer", "text": "Mixed carotenoid formulations are generally preferred for non-smokers seeking general supplementation. Different carotenoids concentrate in different tissues (lycopene in prostate and skin, lutein/zeaxanthin in eyes, astaxanthin systemically, beta-carotene in liver and skin) and provide complementary rather than redundant protection. A formulation providing beta-carotene 5 mg, alpha-carotene 1 mg, lutein 10 mg, zeaxanthin 2 mg, and lycopene 10 mg delivers better tissue coverage than standalone high-dose beta-carotene. For skin photoprotection specifically, astaxanthin 4-8 mg and lycopene 10-20 mg have better evidence than beta-carotene alone. For eye health specifically, lutein plus zeaxanthin is the AREDS2-validated formulation. Isolated beta-carotene supplementation at high doses is indicated only for erythropoietic protoporphyria therapy or vitamin A deficiency correction in specific populations. Dietary diversity of colorful fruits and vegetables provides the most robust multi-carotenoid intake." } } ] }, { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.bodyhackguide.co#organization", "name": "BodyHackGuide", "alternateName": "BHG", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/logo.png", "width": 512, "height": 512 }, "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, real-time vendor pricing, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. BodyHackGuide and BHG Labs share common ownership, and we earn a commission on purchases through our links.", "foundingDate": "2024", "founder": { "@id": "https://www.bodyhackguide.co/about#person" }, "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher", "https://discord.gg/Mhq5UdRYBA" ], "knowsAbout": [ "Peptide research", "Nootropic research", "Biohacking", "Compound dosing", "Vendor transparency" ], "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards", "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards", "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards" } ] --- [Skip to content](#main-content) ## Research Use Only This site is an **educational resource** for research compounds. We do **not endorse** human consumption of any compound. BodyHackGuide and **BHG Labs share common ownership**; we rank every vendor on the same public methodology, and we earn a commission on purchases through our links. By entering, you confirm you are **21 years of age or older** and agree to our [Terms](/terms) & [Privacy Policy](/privacy). I'm 21+ — Enter SiteLeave site [![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp)BodyHackGuide ](/) [Compare](/compare)[Wiki](/wiki)[Vendors](/vendors)[Deals](/deals)[Stacks](/stack-builder)[Nootropics](/nootropics)[Tools](/tools) Learn Community Search ⌘K [Sign In](/auth?returnTo=%2Fcompound%2Fbeta-carotene) 100K+ researchers trust BodyHackGuide — Join [r/BodyHackGuide](https://reddit.com/r/bodyhackguide) 1. [Home](/) 2. [Compounds](/compare) 3. Beta-carotene [Where to buy Beta-carotene](/buy/beta-carotene) [Beta-carotene coupon codes](/coupons/beta-carotene) [Beta-carotene protocol](/protocol/beta-carotene) [Alternatives to Beta-carotene](/alternatives-to/beta-carotene) [Beta-carotene side effects](/side-effects/beta-carotene) 1. [Home](/) 3. [Compounds](/compare) 5. Beta-carotene # Beta-carotene Carotenoid Preclinical Download PDF Also known as: Beta-carotene, beta,beta-Carotene, all-trans-beta-carotene, 9-cis-beta-carotene, 15-cis-beta-carotene, Provitamin A, Carotene, Natural beta-carotene, Synthetic beta-carotene, Dunaliella salina extract, Mixed carotenoids, Food orange 5, E160a, BetaTene, CaroCare Beta-carotene is the most prominent provitamin A carotenoid and one of the most-studied dietary pigments in human nutrition. Chemically it is (all-E)-beta,beta-carotene — two symmetric beta-ionone rings connected by a central 18-carbon polyene chain with 11 conjugated double bonds. Last reviewed: Sep 2, 2026 [ Carotenoid Category ](/wiki#cat-carotenoid) Preclinical Research Stage OverviewChemical InfoDosing & ProtocolsInteractionsResearchCompare PricesRelated ## Overview ### At A Glance Mechanism Beta-carotene acts through three interrelated mechanism clusters: provitamin A activity through enzymatic cleavage to retinal, direct antioxidant function through singlet oxygen quenching and radical scavenging, and modulation of gene expression through both retinoic acid-depende… ### Overview Beta-carotene is the most prominent provitamin A carotenoid and one of the most-studied dietary pigments in human nutrition. Chemically it is (all-E)-beta,beta-carotene — two symmetric beta-ionone rings connected by a central 18-carbon polyene chain with 11 conjugated double bonds. This symmetric bicyclic structure, with identical beta-ionone rings at both ends, distinguishes beta-carotene from its close dietary relatives: alpha-carotene has one beta-ring and one epsilon-ring; gamma-carotene has one beta-ring and an open-chain end; lycopene is fully acyclic with both ends as open isoprenoid chains; lutein and zeaxanthin are the hydroxylated xanthophyll counterparts. Only provitamin A carotenoids with at least one unsubstituted beta-ionone ring can be enzymatically cleaved to retinal (vitamin A) by the human enzyme beta-carotene 15,15'-oxygenase 1 (BCO1); beta-carotene has two such rings and is the most efficient dietary source of vitamin A among carotenoids. The dual role as an antioxidant and as a vitamin A precursor makes beta-carotene distinct from other dietary carotenoids. Unlike lycopene (no vitamin A activity), lutein and zeaxanthin (no vitamin A activity, eye-specific concentration), and astaxanthin (no vitamin A activity, systemic xanthophyll), beta-carotene contributes to vitamin A status in populations where preformed vitamin A intake is low. This is the primary nutritional rationale for beta-carotene fortification of food and for its use in vitamin A deficiency prevention programs in developing countries, particularly through Golden Rice and food fortification in sub-Saharan Africa and South Asia. Historical vitamin A intake, assessed in retinol activity equivalents (RAE), treats beta-carotene as contributing 1 RAE per 12 mcg of dietary beta-carotene (or 1 RAE per 24 mcg of other provitamin A carotenoids). This conversion reflects typical BCO1 cleavage efficiency in mixed dietary matrix and is substantially less efficient than preformed vitamin A from animal sources. The evidence landscape for beta-carotene supplementation underwent a major rethink following two landmark trials published in 1996. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC Study Group 1994, 1996) in 29,133 Finnish male smokers found that beta-carotene 20 mg daily increased lung cancer incidence by 18% and total mortality by 8%. The Beta-Carotene and Retinol Efficacy Trial (CARET, Omenn 1996 NEJM PMID 8602180) in 18,314 heavy smokers and asbestos-exposed workers found that beta-carotene 30 mg plus retinol 25,000 IU daily increased lung cancer incidence by 28% and total mortality by 17%, leading to early termination of the trial. The Physicians' Health Study (Hennekens 1996 NEJM PMID 8602179) in 22,071 predominantly non-smoking male physicians found that beta-carotene 50 mg every other day for 12 years had no effect on cancer or cardiovascular disease, providing reassurance that the smoker-specific signal did not extend to non-smokers. These trials transformed beta-carotene from a promising chemopreventive agent into a supplement with specific contraindication in smokers and former smokers. The AREDS2 trial (Chew 2013 JAMA PMID 23644932) replaced beta-carotene with lutein plus zeaxanthin in the second-generation AREDS formulation specifically because of the smoker safety concern. Current expert recommendations universally discourage isolated high-dose beta-carotene supplementation in current or former smokers, while dietary beta-carotene through food (carrots, sweet potatoes, pumpkin, leafy greens) is considered safe and beneficial in all populations. For non-smoking adults, beta-carotene remains a valid supplementation option within a multi-carotenoid stack, particularly for vitamin A status support in populations with low preformed vitamin A intake, for skin photoprotection, and for general antioxidant coverage. Dietary sources of beta-carotene are abundant: carrots contain 8-12 mg per 100 g, sweet potatoes 6-12 mg, kale 9 mg, spinach 5-6 mg, pumpkin 3-5 mg, apricots and mangoes 1-2 mg, cantaloupe 2-3 mg. A typical Western diet provides 2-5 mg of beta-carotene daily from these sources. Supplemental doses range from 3 mg (typical multivitamin) to 25 mg (standalone beta-carotene or mixed carotenoid formulations). Commercial beta-carotene for supplementation is produced by three routes: extraction from the microalga Dunaliella salina (natural 9-cis and all-trans isomer mixture, richest in 9-cis-beta-carotene which is not present in synthetic preparations), extraction from Blakeslea trispora fungal fermentation, and chemical synthesis (all-trans isomer only, historically used in CARET and ATBC). The Dunaliella-derived natural beta-carotene (BetaTene, Lyc-O-Beta natural, BASF natural beta-carotene) is often preferred because natural isomer mixtures have different bioavailability and tissue distribution compared to purely synthetic all-trans material, and because the natural preparation includes accompanying carotenoids (alpha-carotene, zeaxanthin traces) and tocopherols that may modulate the oxidative chemistry in more physiologic ways. Notably, the ATBC and CARET trials used synthetic all-trans-beta-carotene, and whether natural Dunaliella-derived beta-carotene would have produced the same smoker signal has been debated without definitive resolution; conservative practice treats natural and synthetic equivalently for the smoker contraindication. For bodyhackguide.co users, beta-carotene occupies a specific place in the nutritional landscape: vitamin A status support in vegetarian/vegan populations with limited preformed vitamin A intake, skin photoprotection when combined with other carotenoids, and general antioxidant stacking for non-smokers. It pairs with [lutein](/compound/lutein) and [zeaxanthin](/compound/zeaxanthin) (eye-specific xanthophylls without vitamin A activity), [lycopene](/compound/lycopene) (prostate/cardiovascular acyclic carotenoid), [astaxanthin](/compound/astaxanthin) (systemic xanthophyll), [vitamin-e](/compound/vitamin-e) (membrane antioxidant synergism), and preformed [vitamin-a](/compound/vitamin-a) (retinyl palmitate for populations needing guaranteed vitamin A status). The canonical recommendation is to prioritize dietary beta-carotene intake through colorful plant foods, to avoid standalone high-dose beta-carotene supplementation in current and former smokers, and to use moderate doses (3-10 mg daily) within mixed carotenoid formulations when supplementation is desired in non-smokers. ## Chemical Information IUPAC Name Not yet available CAS Number Not yet available Molecular Formula Not yet available Molecular Mass Not yet available Chemical data is being compiled for this compound. ## Dosing & Protocols ### Unlock Dosing Protocols Free account gets you: - View beginner, intermediate & advanced protocols - See weight-based dosing calculations - Access cycle length & frequency data [Create free account](/auth)[Sign in](/auth) 2,800+ researchers already in ## Research ### Unlock Research Data Free account gets you: - Browse PubMed study summaries - See clinical trial phases & results - Access mechanism of action details [Create free account](/auth)[Sign in](/auth) 2,800+ researchers already in ## Interactions ### Contraindications Contraindications for beta-carotene supplementation are more significant than for most nutritional supplements due to the well-established smoker lung cancer signal. Absolute contraindications: Current smokers and former smokers with substantial smoking history (more than 10 pack-years, or quit within the past 15 years) — avoid standalone high-dose beta-carotene supplementation. CARET and ATBC trials established increased lung cancer risk at 20-30 mg daily in these populations. Multivitamin-level doses (1-3 mg) are considered acceptable but should also be minimized. This contraindication is universally accepted by major professional societies. Asbestos-exposed workers — CARET specifically enrolled this population and found harm. Avoid high-dose supplementation regardless of current smoking status. Relative contraindications and caution situations: Heavy alcohol consumers — ATBC subgroup analysis suggested amplified lung cancer signal with high alcohol plus beta-carotene. Moderate intake within mixed carotenoid formulations is acceptable; standalone high-dose beta-carotene should be avoided. Prior lung cancer, head and neck cancer, or esophageal cancer survivors — avoid high-dose beta-carotene supplementation for life. Dietary intake through food is acceptable. Patients on oral retinoid therapy (isotretinoin, acitretin, bexarotene) — additional beta-carotene supplementation is generally unnecessary and adds no benefit to retinoid therapy. Dietary intake is acceptable. Patients on high-dose preformed vitamin A supplementation — adding beta-carotene does not significantly increase vitamin A status because intestinal conversion downregulates when vitamin A is adequate. Unnecessary additive supplementation. Liver disease — monitor if high-dose supplementation is used. No hepatotoxicity signal but severe hepatic disease may alter beta-carotene metabolism and storage. Fat malabsorption (cystic fibrosis, chronic pancreatitis, extensive small bowel resection, bile acid deficiency, steatorrhea syndromes) — absorption is limited. Use water-miscible formulations or pair with enzyme replacement therapy. Monitor serum levels. Cholestyramine, colestipol, orlistat — reduce absorption. Separate doses by 2-4 hours. Pregnancy — dietary intake is safe and encouraged. Supplemental doses within prenatal multivitamin levels (3-5 mg daily) are safe and actually preferred over preformed retinyl palmitate because beta-carotene cannot produce teratogenic hypervitaminosis A. Very high-dose supplementation (>25 mg daily) during pregnancy has not been studied and should be avoided unless medically indicated. Lactation — dietary intake is safe. Supplementation at typical doses is acceptable. Pediatric use — dietary intake is safe and beneficial. Supplemental use in healthy children is not routinely indicated. Specific indications (EPP, severe malabsorption, vitamin A deficiency in developing countries) warrant pediatric dosing under medical guidance. Allergic reactions — rare. Typical supplement excipients (gelatin, vegetable oil carriers) may trigger reactions in sensitive individuals. Natural Dunaliella-derived products contain trace algal proteins and should be avoided in patients with documented algal protein allergy. Simultaneous multi-carotenoid megadosing — absorption competition reduces the effective dose of each carotenoid. Practical impact is small at typical doses but relevant at research-dose levels. Medical conditions where beta-carotene is ACTIVELY RECOMMENDED: Erythropoietic protoporphyria (EPP) — beta-carotene 120-180 mg daily (adults) is established pharmacologic therapy for reducing photosensitivity. Specialist dermatologic supervision. Vitamin A deficiency in developing countries — dietary beta-carotene or biofortified foods (orange-fleshed sweet potato, Golden Rice, beta-carotene-enhanced maize) is a public health intervention strategy. Polymorphous light eruption — beta-carotene 30-60 mg daily as adjunctive photoprotection (limited evidence). Conditions where beta-carotene is NOT RECOMMENDED: Cardiovascular disease prevention — trials have been null. Use other cardiovascular interventions. Cancer chemoprevention (outside EPP and specific deficiency contexts) — trials have been null or harmful. Do not use for this indication. Age-related macular degeneration — use AREDS2 formulation (lutein plus zeaxanthin substitution). General population cancer prevention — dietary intake through food only. Overall, beta-carotene supplementation has a narrower appropriate use case than most nutritional supplements due to the smoker contraindication and null interventional evidence for most chronic disease endpoints outside of deficiency states. Dietary intake through colorful plant foods remains universally beneficial; supplementation should be approached with clear indication, moderate dosing, and awareness of smoking history. Research Disclaimer This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds. [Sign in for alerts ](/auth) No listings found for Beta-carotene. Get Beta-carotene Price Drop Alerts Set a target price and we'll notify you when any vendor drops below it. [Sign in to set alerts](/auth) ### Sign in to leave a review Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with Beta-carotene. [Sign in](/auth) ### Related Compounds [View All](/wiki) [ ### Astaxanthin Carotenoid Preclinical Astaxanthin is a red-orange keto-carotenoid xanthophyll, chemically classified as a 3,3''-dihydroxy-beta,beta-carotene-4,4''-dione. 4720 studies View Profile ](/compound/astaxanthin)[ ### Lutein Carotenoid Preclinical Lutein is a dihydroxy-xanthophyll carotenoid that functions as the primary blue-light-absorbing, antioxidant macular pigment of the human retina, where along with its stereoisomers zeaxanthin and meso-zeaxanthin it concentrates selectively in the central macula at concentrations exceeding 1,000 times those found in any other body tissue. 35637 studies View Profile ](/compound/lutein)[ ### Lycopene Carotenoid Preclinical Lycopene is a red pigment carotenoid belonging to the acyclic hydrocarbon carotene subfamily, chemically designated psi,psi-carotene. Preclinical View Profile ](/compound/lycopene)[ ### Zeaxanthin Carotenoid Preclinical Zeaxanthin is a xanthophyll carotenoid that functions alongside lutein and meso-zeaxanthin as one of the three pigments comprising the macula lutea — the yellow spot in the central retina responsible for high-acuity daytime vision. Preclinical View Profile ](/compound/zeaxanthin) [ View Full Dosage Guide → Protocols, calculator & safety for Beta-carotene ](/guides/dosage/beta-carotene) ### Research Score 15 0 PubMed studies ### Quality Indicators Data Completeness 50% Description Mechanism of Action Chemical Data Dosing Protocols Safety Profile PubMed Studies Interactions Vendor Listings ### Quick Facts Trial Phase Preclinical [Full Dosage Guide](/guides/dosage/beta-carotene)[Calculate Your Dose](/tools/reconstitution) Research Disclaimer This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use. ## Frequently Asked Questions Why is beta-carotene dangerous for smokers? Two landmark trials established that high-dose beta-carotene supplementation increases lung cancer risk in heavy smokers. The ATBC trial (1994) in 29,133 Finnish male smokers found 20 mg daily beta-carotene increased lung cancer incidence by 18%. The CARET trial (Omenn 1996 NEJM PMID 8602180) in 18,314 heavy smokers and asbestos workers found 30 mg plus retinol 25,000 IU daily increased lung cancer by 28% and was terminated early. The proposed mechanism involves pro-oxidant eccentric cleavage of beta-carotene in high-oxygen smoker lung tissue, producing reactive aldehyde metabolites that contribute to carcinogenesis. Dietary beta-carotene through food (carrots, sweet potatoes, greens) has not shown this signal and remains safe for smokers; the problem is isolated high-dose supplementation only. Former smokers are typically advised to avoid high-dose supplementation for at least 15 years after quitting. Is dietary beta-carotene safe for smokers? Yes. The CARET and ATBC trials used synthetic beta-carotene pills at 20-30 mg daily. Dietary intake through food provides comparable doses but with very different pharmacokinetics — slower absorption, presence of accompanying phytonutrients, and tissue distribution that does not replicate the harmful signal. Observational studies consistently show that dietary fruit and vegetable consumption is associated with lower cancer risk, including in smokers. Smokers should continue to eat carrots, sweet potatoes, spinach, pumpkin, and other beta-carotene-rich foods; only isolated high-dose supplementation (20 mg daily or more) is contraindicated. Small amounts of beta-carotene in standard multivitamins (1-3 mg) are generally considered acceptable. Is natural Dunaliella-derived beta-carotene safer than synthetic? Possibly, but not definitively established. The CARET and ATBC trials used synthetic all-trans-beta-carotene, not natural Dunaliella-derived beta-carotene. Natural Dunaliella contains approximately 50% 9-cis-beta-carotene (absent from synthetic preparations) plus accompanying carotenoids and tocopherols. Some researchers have argued that the 9-cis form and accompanying phytonutrients may produce different (potentially safer) oxidative chemistry than pure all-trans synthetic beta-carotene. However, no randomized trial has directly compared natural versus synthetic beta-carotene in smokers for lung cancer outcomes, and the conservative clinical recommendation is to treat all beta-carotene supplementation forms equivalently for the smoker contraindication. Natural Dunaliella is preferred over synthetic in non-smokers for general quality and phytonutrient diversity reasons. Should I take beta-carotene for vitamin A? It depends on your vitamin A status, BCO1 genotype, and preformed vitamin A intake. Beta-carotene is the safer source of vitamin A than preformed retinyl palmitate because it cannot cause hypervitaminosis A or teratogenicity — intestinal conversion to retinal is saturable. However, BCO1 polymorphisms (R267S, A379V) reduce conversion efficiency by 40-50% in approximately 45% of the population, making beta-carotene less reliable for those carriers. Vegans, strict vegetarians, and people with limited animal food intake benefit from beta-carotene contribution to vitamin A status. Those with adequate preformed vitamin A intake (eggs, dairy, fish, liver) typically don't need additional beta-carotene for vitamin A status. Preformed vitamin A from a prenatal or high-quality multivitamin (2500-5000 IU) provides guaranteed vitamin A status without conversion uncertainty. What happens if I take too much beta-carotene? The most common effect of high-dose intake is carotenodermia — a yellow-orange pigmentation of the skin, particularly visible on the palms, soles, and nasolabial folds. Carotenodermia occurs at sustained intakes above 20-30 mg daily from all sources (food plus supplements) and is completely reversible within 2-6 weeks of reduced intake. Unlike jaundice, carotenodermia does not affect the sclera of the eyes (eyes remain white). Beta-carotene cannot cause hypervitaminosis A because conversion to retinol is saturable — your body stops converting when vitamin A status is adequate. No hepatotoxicity. No teratogenicity. The only clinically significant concern at high doses is the smoker lung cancer signal; non-smokers taking 25-50 mg daily for skin photoprotection or EPP therapy do not show clinical toxicity aside from cosmetic carotenodermia. Why did AREDS2 remove beta-carotene from the eye health formula? Because of the smoker lung cancer safety signal from CARET and ATBC. The original AREDS trial (2001) included beta-carotene 15 mg daily as part of the AMD prevention formulation, but by the time AREDS2 was designed it was clear that beta-carotene should be avoided in any population including smokers. AREDS2 tested whether lutein 10 mg plus zeaxanthin 2 mg could replace beta-carotene while maintaining AMD prevention benefit — the answer was yes, with non-inferior AMD outcomes and superior safety in former smokers. AREDS2 is now the evidence-based standard, and any eye health formulation sold today for AMD prevention should use lutein plus zeaxanthin rather than beta-carotene. Patients with any smoking history should only use AREDS2-style formulations. Can I take beta-carotene during pregnancy? Yes, at appropriate doses. Dietary beta-carotene through carrots, sweet potatoes, spinach, and other colorful vegetables is safe and encouraged during pregnancy. Supplemental beta-carotene at doses up to 25,000 IU (15 mg) daily within a prenatal multivitamin is safe — actually preferred over preformed retinyl palmitate because beta-carotene cannot cause teratogenic hypervitaminosis A. The retinol teratogenicity threshold (approximately 10,000 IU daily of preformed vitamin A) does not apply to beta-carotene. Very high-dose beta-carotene supplementation (25+ mg daily) during pregnancy has not been well-studied and should be avoided unless medically indicated. Most prenatal vitamins use beta-carotene as the primary vitamin A source for this safety reason. Does beta-carotene help with skin sun protection? Modestly, yes, in non-smokers. Studies by Mathews-Roth in the 1970s and more recent work by Heinrich 2003 have shown that beta-carotene 15-30 mg daily for several months increases minimal erythema dose (the UV exposure threshold for visible skin erythema) by 20-40%. The effect is cumulative over weeks to months, not acute. Mechanism involves beta-carotene accumulation in skin, direct UV photon absorption, and singlet oxygen quenching of UV-induced ROS. The oral photoprotection effect is modest (equivalent to roughly SPF 1-2) and does NOT replace topical sunscreen for sun protection. Lycopene and astaxanthin provide similar or stronger oral photoprotection and are preferred in smokers; for non-smokers, combining beta-carotene with other carotenoids provides best-case oral photoprotection. What are the best food sources of beta-carotene? Orange and deep green vegetables are richest. Sweet potatoes (cooked, 12 mg per medium), carrots (6-8 mg per medium raw), kale (9 mg per cup cooked), spinach (11 mg per cup cooked), pumpkin (7 mg per cup cooked), butternut squash (9 mg per cup cooked), cantaloupe (7 mg per half), mango (2 mg per medium), and apricots (0.5 mg each) are the major dietary sources. Tomatoes and red peppers contain modest beta-carotene alongside their higher lycopene or lutein content. For maximum absorption, cook with fat (olive oil, butter, or ghee) — beta-carotene absorption from a fat-free meal can be near zero, while absorption with adequate dietary fat ranges from 10-30%. A typical Western diet provides 2-5 mg daily; adding one sweet potato serving or large kale salad daily easily achieves 10-15 mg dietary intake, meeting or exceeding typical supplementation doses. Should I take beta-carotene or a mixed carotenoid formulation? Mixed carotenoid formulations are generally preferred for non-smokers seeking general supplementation. Different carotenoids concentrate in different tissues (lycopene in prostate and skin, lutein/zeaxanthin in eyes, astaxanthin systemically, beta-carotene in liver and skin) and provide complementary rather than redundant protection. A formulation providing beta-carotene 5 mg, alpha-carotene 1 mg, lutein 10 mg, zeaxanthin 2 mg, and lycopene 10 mg delivers better tissue coverage than standalone high-dose beta-carotene. For skin photoprotection specifically, astaxanthin 4-8 mg and lycopene 10-20 mg have better evidence than beta-carotene alone. For eye health specifically, lutein plus zeaxanthin is the AREDS2-validated formulation. Isolated beta-carotene supplementation at high doses is indicated only for erythropoietic protoporphyria therapy or vitamin A deficiency correction in specific populations. Dietary diversity of colorful fruits and vegetables provides the most robust multi-carotenoid intake. ## Research Tools [ ### Peptide Calculator Reconstitution & syringe units ](/tools/reconstitution)[ ### Reconstitution Guide How to mix, step by step ](/guides/how-to-reconstitute-peptides)[ ### Nasal Spray Calc mL per actuation ](/tools/intranasal)[ ### Half-Life Visualizer Decay curves ](/tools/halflife) ## Related Compounds [View All](/wiki) [ ### Astaxanthin Carotenoid Preclinical Astaxanthin is a red-orange keto-carotenoid xanthophyll, chemically classified as a 3,3''-dihydroxy-beta,beta-carotene-4,4''-dione. 4720 studies View Profile ](/compound/astaxanthin)[ ### Lutein Carotenoid Preclinical Lutein is a dihydroxy-xanthophyll carotenoid that functions as the primary blue-light-absorbing, antioxidant macular pigment of the human retina, where along with its stereoisomers zeaxanthin and meso-zeaxanthin it concentrates selectively in the central macula at concentrations exceeding 1,000 times those found in any other body tissue. 35637 studies View Profile ](/compound/lutein)[ ### Lycopene Carotenoid Preclinical Lycopene is a red pigment carotenoid belonging to the acyclic hydrocarbon carotene subfamily, chemically designated psi,psi-carotene. Preclinical View Profile ](/compound/lycopene)[ ### Zeaxanthin Carotenoid Preclinical Zeaxanthin is a xanthophyll carotenoid that functions alongside lutein and meso-zeaxanthin as one of the three pigments comprising the macula lutea — the yellow spot in the central retina responsible for high-acuity daytime vision. Preclinical View Profile ](/compound/zeaxanthin) Free 2026 Peptide Cheat Sheet — 50 pages, PDF Reconstitution math, concentration charts, half-lives, and vendor trust tiers. The reference we wish we had on day one. [Download Free](/guides/peptide-cheat-sheet-download?utm_source=compound-beta-carotene) ### Need bloodwork before starting? Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount. [Order Bloodwork](https://anabolicinsights.ai/?ref=nwm2zjb) ![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp) ### BodyHackGuide Your biohacking research hub — compound pricing, brain health protocols, dosing tools, and vendor reviews. [support@bodyhackguide.co](mailto:support@bodyhackguide.co) [](https://discord.gg/Mhq5UdRYBA)[](https://reddit.com/r/BodyHackGuide)[](https://x.com/bodyhackguide) Explore #### Explore - [Compare prices](/compare) - [Research suppliers](/vendors) - [Deals](/deals) - [Coupons](/coupons) - [Nootropics](/nootropics) - [Brain health](/brain-health) - [Blog](/blog) - [Guides](/guides) Tools #### Tools - [Reconstitution](/tools/reconstitution) - [Dosage calculator](/tools/dosage) - [Half-life visualizer](/tools/halflife) - [COA lookup](/tools/coa) - [Cost calculator](/tools/cost-calculator) - [Stack builder](/stack-builder) - [All tools →](/tools) Trust & vendors #### Trust & vendors - [Vendor directory](/vendors) - [Trust scorecard](/vendors/scorecard) - [Get BHG verified](/vendors/get-vetted) - [Scoring methodology](/vendors/methodology) - [Peptide cheatsheet](/guides/peptide-cheat-sheet-download) Company #### Company - [About](/about) - [Affiliate disclosure](/affiliate-disclosure) - [Editorial standards](/editorial-standards) - [Creators](/creators) - [Coaches](/coaches) - [Privacy](/privacy) - [Terms](/terms) - [Full site directory →](/site-directory) **Ownership & Affiliate Disclosure:** BodyHackGuide and BHG Labs share common ownership. We rank every vendor on the same public, reproducible [methodology](/vendors/methodology), and we earn a commission from purchases made through our links at no extra cost to you. Full details in our [affiliate disclosure](/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell, distribute, or promote any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. · [Terms](/terms) · [Privacy](/privacy) hi 👋